US2006057166A1PendingUtilityA1

Methods for treating Raynaud's syndrome

48
Assignee: ALLERGAN INCPriority: Jan 8, 2004Filed: Oct 19, 2005Published: Mar 16, 2006
Est. expiryJan 8, 2024(expired)· nominal 20-yr term from priority
Inventors:Mitchell F. BrinMarkus Naumann
A61P 9/08A61P 25/02A61K 38/4893
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for treating Raynaud's syndrome by administering a botulinum toxin directly to an afflicted tissue of a patient.

Claims

exact text as granted — not AI-modified
1 . A method for treating Raynaud's syndrome of a patient in need thereof, the method comprising the step of administering a botulinum toxin to a tissue afflicted with Raynaud's syndrome, thereby increasing blood supply in the afflicted tissue and treating Raynaud's syndrome.  
   
   
       2 . The method of  claim 1  wherein the administering includes the step of injecting the botulinum toxin into a wall of the blood vessel.  
   
   
       3 . The method of  claim 1  wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.  
   
   
       4 . The method of  claim 1  wherein the botulinum toxin is a botulinum toxin type A.

Join the waitlist — get patent alerts

Track US2006057166A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.